» Articles » PMID: 29150892

Expanding the Neurodevelopmental Phenotype of PURA Syndrome

Abstract

PURA syndrome is a recently described developmental encephalopathy presenting with neonatal hypotonia, feeding difficulties, global developmental delay, severe intellectual disability, and frequent apnea and epilepsy. We describe 18 new individuals with heterozygous sequence variations in PURA. A neuromotor disorder starting with neonatal hyptonia, but ultimately allowing delayed progression to walking, was present in nearly all individuals. Congenital apnea was present in 56% during infancy, but all cases in this cohort resolved during the first year of life. Feeding difficulties were frequently reported, with gastrostomy tube placement required in 28%. Epilepsy was present in 50% of the subjects, including infantile spasms and Lennox-Gastaut syndrome. Skeletal complications were found in 39%. Disorders of gastrointestinal motility and nystagmus were also recurrent features. Autism was diagnosed in one individual, potentially expanding the neurodevelopmental phenotype associated with this syndrome. However, we did not find additional PURA sequence variations in a cohort of 120 subjects with autism. We also present the first neuropathologic studies of PURA syndrome, and describe chronic inflammatory changes around the arterioles within the deep white matter. We did not find significant correlations between mutational class and severity, nor between location of the sequence variation in PUR repeat domains. Further studies are required in larger cohorts of subjects with PURA syndrome to clarify these genotype-phenotype associations.

Citing Articles

First report of PURA syndrome in a Colombian patient with de novo missense variant c.692T>C (p.Phe231Ser).

Ceron S, Perez D, Montano J, Acosta M Biomedica. 2024; 44(4):441-450.

PMID: 39531550 PMC: 11781598. DOI: 10.7705/biomedica.7286.


Incidence of hip problems in developmental central hypotonia: A scoping review.

Livingstone R, Paleg G, Shrader M, Miller F, Rodby-Bousquet E Dev Med Child Neurol. 2024; 67(3):307-321.

PMID: 39429029 PMC: 11794678. DOI: 10.1111/dmcn.16124.


Inherited Pathogenic Variant Associated With a Mild Neurodevelopmental Disorder.

Hildebrand M, Braden R, Lauretta M, Kaspi A, Leventer R, Anderson M Neurol Genet. 2024; 10(5):e200181.

PMID: 39131487 PMC: 11309559. DOI: 10.1212/NXG.0000000000200181.


PURA syndrome-causing mutations impair PUR-domain integrity and affect P-body association.

Proske M, Janowski R, Bacher S, Kang H, Monecke T, Koehler T Elife. 2024; 13.

PMID: 38655849 PMC: 11042805. DOI: 10.7554/eLife.93561.


Case Report: Expanding the phenotypic spectrum of PURA syndrome in South America with the first presentation of concurrent vitiligo.

Mora-Martinez S, Castano-Giraldo N, Nati-Castillo H, Barahona Machado L, Mora Arbelaez T, Gordillo-Gonzalez G Front Pediatr. 2024; 12:1323014.

PMID: 38606370 PMC: 11007168. DOI: 10.3389/fped.2024.1323014.


References
1.
Amiel J, Rio M, De Pontual L, Redon R, Malan V, Boddaert N . Mutations in TCF4, encoding a class I basic helix-loop-helix transcription factor, are responsible for Pitt-Hopkins syndrome, a severe epileptic encephalopathy associated with autonomic dysfunction. Am J Hum Genet. 2007; 80(5):988-93. PMC: 1852736. DOI: 10.1086/515582. View

2.
McMahon K, Papandreou A, Ma M, Barry B, Mirzaa G, Dobyns W . Familial recurrences of FOXG1-related disorder: Evidence for mosaicism. Am J Med Genet A. 2015; 167A(12):3096-102. PMC: 4715619. DOI: 10.1002/ajmg.a.37353. View

3.
Ramirez J, Ward C, Neul J . Breathing challenges in Rett syndrome: lessons learned from humans and animal models. Respir Physiol Neurobiol. 2013; 189(2):280-7. PMC: 3812329. DOI: 10.1016/j.resp.2013.06.022. View

4.
Le Meur N, Holder-Espinasse M, Jaillard S, Goldenberg A, Joriot S, Amati-Bonneau P . MEF2C haploinsufficiency caused by either microdeletion of the 5q14.3 region or mutation is responsible for severe mental retardation with stereotypic movements, epilepsy and/or cerebral malformations. J Med Genet. 2009; 47(1):22-9. PMC: 2848840. DOI: 10.1136/jmg.2009.069732. View

5.
Tanaka A, Bai R, Cho M, Anyane-Yeboa K, Ahimaz P, Wilson A . De novo mutations in PURA are associated with hypotonia and developmental delay. Cold Spring Harb Mol Case Stud. 2016; 1(1):a000356. PMC: 4850890. DOI: 10.1101/mcs.a000356. View